The best-characterized type 1 interferon (IFN) signaling pathway depends on signal transducer and activator of transcription 1 (STAT1) and STAT2. The cytokines can, however, conditionally activate all STATs. Regulation of their access to particular signaling pathways is poorly understood. STAT4 is important for IFN-γ induction, and NK cells are major producers of this cytokine. We report that NK cells have high basal STAT4 levels and sensitivity to type 1 IFN–mediated STAT4 activation for IFN-γ production. Increases in STAT1, driven during viral infection by either type 1 IFN or IFN-γ, are associated with decreased STAT4 access. Both STAT1 and STAT2 are important for antiviral defense, but STAT1 has a unique role in protecting against sustained NK cell IFN-γ production and resulting disease. The regulation occurs with an NK cell type 1 IFN receptor switch from a STAT4 to a STAT1 association. Thus, a fundamental characteristic of NK cells is high STAT4 bound to the type 1 IFN receptor. The conditions of infection result in STAT1 induction with displacement of STAT4. These studies elucidate the critical role of STAT4 levels in predisposing selection of specific signaling pathways, define the biological importance of regulation within particular cell lineages, and provide mechanistic insights for how this is accomplished in vivo.
Skip Nav Destination
Article navigation
1 October 2007
Article|
September 10 2007
High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells
Takuya Miyagi,
Takuya Miyagi
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Search for other works by this author on:
M. Pilar Gil,
M. Pilar Gil
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Search for other works by this author on:
Xin Wang,
Xin Wang
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Search for other works by this author on:
Jennifer Louten,
Jennifer Louten
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Search for other works by this author on:
Wen-Ming Chu,
Wen-Ming Chu
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Search for other works by this author on:
Christine A. Biron
Christine A. Biron
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Search for other works by this author on:
Takuya Miyagi
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
M. Pilar Gil
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Xin Wang
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Jennifer Louten
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Wen-Ming Chu
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
Christine A. Biron
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
CORRESPONDENCE Christine A. Biron: [email protected]
Abbreviations used: IFNAR, IFN-α/β receptor; LCMV, lymphocytic choriomeningitis virus; rm, recombinant mouse; SOCS, suppressor of cytokine signaling; STAT, signal transducer and activator of transcription.
M.P. Gil and X. Wang contributed equally to this work.
J. Louten's present address is Schering-Plough Biopharma, Palo Alto, CA 94304.
Received:
February 26 2007
Accepted:
August 16 2007
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2007
J Exp Med (2007) 204 (10): 2383–2396.
Article history
Received:
February 26 2007
Accepted:
August 16 2007
Citation
Takuya Miyagi, M. Pilar Gil, Xin Wang, Jennifer Louten, Wen-Ming Chu, Christine A. Biron; High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells . J Exp Med 1 October 2007; 204 (10): 2383–2396. doi: https://doi.org/10.1084/jem.20070401
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement